<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="Publisher" Owner="NLM"><PMID Version="1">39482218</PMID><DateRevised><Year>2024</Year><Month>10</Month><Day>31</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1879-9809</ISSN><JournalIssue CitedMedium="Internet"><PubDate><Year>2024</Year><Month>Oct</Month><Day>30</Day></PubDate></JournalIssue><Title>PET clinics</Title><ISOAbbreviation>PET Clin</ISOAbbreviation></Journal><ArticleTitle>Long Coronavirus Disease and the Brain: Molecular Neuroimaging Insights into Neurologic and Psychiatric Sequelae.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">S1556-8598(24)00084-1</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.cpet.2024.09.013</ELocationID><Abstract><AbstractText>The coronavirus disease 2019 (COVID-19) pandemic has led to a variety of health challenges, with "long COVID" emerging as a widespread and debilitating post-acute syndrome among a considerable number of infected patients. This PET review synthesizes current evidence of the neurologic and psychiatric sequelae of COVID. This review also explores the pathophysiological mechanisms of these results, including astrocyte dysfunction and glutamate dysregulation, as well as the multimodal comparison to MR imaging findings. The findings underscore the potential for long-term brain injury. Additionally, the authors discuss the role of advanced imaging multimodal techniques in diagnosing, monitoring, and guiding treatment strategies for long COVID.</AbstractText><CopyrightInformation>Copyright &#xa9; 2024 Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Guedj</LastName><ForeName>Eric</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Biophysics and Nuclear Medicine, Aix Marseille University, Marseille, France; APHM, CNRS, Centrale Marseille, Institut Fresnel, Timone Hospital, Marseille, France; Nuclear Medicine Department, CERIMED, Marseille, France. Electronic address: eric.guedj@univ-amu.fr.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cionca</LastName><ForeName>Alexandre</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Neuro-X Institute, &#xc9;cole Polytechnique F&#xe9;d&#xe9;rale de Lausanne (EPFL), Lausanne, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>P&#xe9;ron</LastName><ForeName>Julie A</ForeName><Initials>JA</Initials><AffiliationInfo><Affiliation>Clinical and Experimental Neuropsychology Laboratory, Faculty of Psychology, University of Geneva, Geneva, Switzerland; Neurology Division, Geneva University Hospitals, Geneva, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ayubcha</LastName><ForeName>Cyrus</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Harvard Medical School, Boston, MA, USA; Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Assal</LastName><ForeName>Fr&#xe9;d&#xe9;ric</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Neurology Division, Geneva University Hospitals, Geneva, Switzerland; Faculty of Medicine, University of Geneva, Geneva, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Horowitz</LastName><ForeName>Tatiana</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Biophysics and Nuclear Medicine, Aix Marseille University, Marseille, France; APHM, CNRS, Centrale Marseille, Institut Fresnel, Timone Hospital, Marseille, France; Nuclear Medicine Department, CERIMED, Marseille, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Alavi</LastName><ForeName>Abass</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Radiology, University of Pennsylvania, Philadelphia, PA, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>10</Month><Day>30</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>PET Clin</MedlineTA><NlmUniqueID>101260152</NlmUniqueID><ISSNLinking>1556-8598</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Brain</Keyword><Keyword MajorTopicYN="N">COVID</Keyword><Keyword MajorTopicYN="N">Long COVID</Keyword><Keyword MajorTopicYN="N">Molecular neuroimaging</Keyword><Keyword MajorTopicYN="N">Psychiatric sequelae</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>11</Month><Day>1</Day><Hour>0</Hour><Minute>21</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>11</Month><Day>1</Day><Hour>0</Hour><Minute>21</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>10</Month><Day>31</Day><Hour>23</Hour><Minute>3</Minute></PubMedPubDate></History><PublicationStatus>aheadofprint</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39482218</ArticleId><ArticleId IdType="doi">10.1016/j.cpet.2024.09.013</ArticleId><ArticleId IdType="pii">S1556-8598(24)00084-1</ArticleId></ArticleIdList></PubmedData></PubmedArticle></PubmedArticleSet>